AXCELIS TECHNOLOGIES INC financials

  1. Home
  2. Financials
  3. ACLS
ACLS CIK 0001113232

Source: EDGAR filings · Built 2026-06-02T02:13:51Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow 105.65M 127.11M 134.97M 203.94M 140.71M 61.87M
EBITDA 136.93M 226.60M 278.86M 223.97M 138.14M 67.98M
Working Capital 745.54M 916.09M 794.86M 629.51M 469.11M 386.36M
Net Debt -73.65M -50.05M -91.41M -126.88M -238.46M -150.81M
Gross Margin 44.91% 44.67% 43.45% 43.67% 43.24% 41.85%
Operating Margin 14.22% 20.71% 23.51% 23.08% 19.22% 12.23%
Net Margin 14.33% 19.75% 21.78% 19.90% 14.89% 10.53%
Return on Equity (ROE) 11.62% 19.85% 28.47% 27.44% 18.30% 10.38%
Return on Assets (ROA) 8.83% 14.90% 19.21% 18.06% 13.10% 8.00%
Current Ratio 4.77× 5.41× 3.79× 3.54× 4.12× 5.58×
Debt-to-Equity 0.07× 0.07× 0.09× 0.09× 0.10× 0.11×
Effective Tax Rate 13.03% 12.72% 11.61% 10.64% 18.08% 10.56%
Cash Conversion Ratio 0.98× 0.70× 0.64× 1.18× 1.52× 1.39×
Accruals Ratio 0.00× 0.04× 0.07× -0.03× -0.07× -0.03×
SBC % of Revenue 2.48% 2.06% 1.62% 1.46% 1.82% 2.21%
CapEx Coverage 9.35× 10.27× 7.16× 18.48× 15.84× 8.90×
Free Cash Flow Per Share $3.34 $3.89 $4.07 $6.08 $4.11 $1.81

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) 21.14× 11.36× 17.45× 14.53× 25.89× 19.95×
P/FCF 24.08× 17.98× 31.87× 13.05× 18.16× 16.06×
FCF Yield 4.15% 5.56% 3.14% 7.66% 5.51% 6.23%
EV / EBITDA 17.48× 9.76× 14.87× 11.05× 16.21× 12.19×
P/S 2.94× 2.22× 3.75× 2.83× 3.74× 2.06×
P/B 2.39× 2.23× 4.90× 3.90× 4.60× 2.03×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax 839.05M 1.02B 1.13B 920.00M 662.43M 474.56M
Revenues 839.05M 1.02B 1.13B 920.00M 662.43M 474.56M
Cost of Goods and Services Sold 462.20M 563.21M 639.30M 518.21M 375.98M 275.98M
Gross Profit 376.85M 454.65M 491.30M 401.79M 286.44M 198.58M
Research and Development Expense 108.96M 105.50M 96.91M 78.36M 65.43M 61.83M
Operating Expenses 257.53M 243.86M 225.51M 189.43M 159.12M 140.54M
Operating Income (Loss) 119.31M 210.79M 265.80M 212.36M 127.33M 58.04M
Income Tax Expense (Benefit) 18.01M 29.28M 32.34M 21.81M 21.78M 5.90M
Net Income (Loss) Attributable to Parent 120.24M 200.99M 246.26M — — —
Earnings Per Share, Basic $3.81 $6.17 $7.52 $5.54 $2.94 $1.50
Weighted Average Number of Shares Outstanding, Basic 31.57M 32.55M 32.76M 33.04M 33.55M 33.26M
Earnings Per Share, Diluted $3.80 $6.15 $7.43 $5.46 $2.88 $1.46
Weighted Average Number of Shares Outstanding, Diluted 31.67M 32.70M 33.16M 33.54M 34.27M 34.13M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 145.45M 123.51M 167.30M 185.59M 294.92M 203.48M
Assets, Current 943.20M 1.12B 1.08B 877.64M 619.25M 470.79M
Assets 1.36B 1.35B 1.28B 1.01B 753.24M 624.62M
Liabilities, Current 197.66M 207.52M 285.13M 248.13M 150.14M 84.43M
Liabilities 326.67M 335.99M 417.08M 346.38M 214.28M 143.02M
Stockholders' Equity Attributable to Parent 1.03B 1.01B 864.88M 667.26M 538.96M 481.60M
Common Stock, Shares, Outstanding 30.72M 32.37M 32.69M 32.77M 33.24M 33.63M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 118.31M 140.82M 156.87M 215.61M 150.19M 69.70M
Payments to Acquire Property, Plant, and Equipment 11.29M 12.18M 20.66M 10.68M 8.72M 7.43M
Net Cash Provided by (Used in) Investing Activities 29.93M -108.73M -100.86M -257.25M -8.72M -7.27M
Payments for Repurchase of Common Stock 121.08M 60.49M 52.50M 57.49M 49.99M 7.50M
Net Cash Provided by (Used in) Financing Activities -124.49M -71.19M -68.27M -65.48M -52.45M -2.39M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (ACLS CIK 0001113232), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

HAIN

THE HAIN CELESTIAL GROUP, INC.

RAPP

Rapport Therapeutics, Inc.

ARTV

Artiva Biotherapeutics, Inc.